Table 2.
Stroke symptoms and administered medications (not mutually exclusive).
|
All patients (n = 448) |
Ischemic (n = 141) |
Hemorrhagic (n = 82) |
Undetermined (225) |
|
|---|---|---|---|---|
| STROKE SYMPTOMS | ||||
| Hemiplegia | 81 (18.1%) | 15 (10.6%) | 8 (9.8%) | 58 (25.8%) |
| Hemiparesis | 302 (67.4%) | 112 (79.4%) | 57 (69.5%) | 133 (59.1%) |
| Abnormal body movement | 30 (6.7%) | 12 (8.5%) | 6 (7.3%) | 12 (5.3%) |
| Communication difficulties | 251 (56.0%) | 85 (60.3%) | 41 (50.0%) | 125 (55.6%) |
| Facial palsy | 167 (37.3%) | 62 (44.0%) | 22 (26.8%) | 83 (36.9%) |
| Coma or altered mentation | 88 (19.6%) | 31 (22.0%) | 11 (13.4%) | 46 (20.4%) |
| Repeated vomiting | 117 (26.1%) | 39 (27.7%) | 18 (22.0%) | 60 (26.7%) |
| Globalized headache | 163 (36.4%) | 53 (37.6%) | 25 (30.5%) | 85 (37.8%) |
| Incontinence | 55 (12.3%) | 14 (9.9%) | 7 (8.5%) | 34 (15.1%) |
| ADMINISTERED MEDICATIONS | ||||
| Aspirin | 291 (65.0%) | 96 (68.1%) | 57 (69.5%) | 138 (61.3%) |
| Statin | 337 (75.2%) | 110 (78.0%) | 63 (76.8%) | 164 (72.9%) |
| Antihypertensive | 314 (70.1%) | 106 (75.2%) | 60 (73.2%) | 148 (65.8%) |
| Anticoagulant | 89 (19.9%) | 26 (18.4%) | 10 (12.2%) | 53 (23.6%) |
| Antibiotic | 78 (17.4%) | 19 (13.5%) | 16 (19.5%) | 43 (19.1%) |
| Diuretic | 37 (8.3%) | 4 (2.8%) | 8 (9.8%) | 25 (11.0%) |
Statins, Atorvastatin (oral), Simvastatin (oral); antihypertensives, Amlodipine (oral), Enalapril (oral), Labetalol (oral), Anticoagulants, Warfarin (oral), Heparin (IV); Antibiotics, Azithromycin (oral), Metronidazole (IV); Ceftriaxone (IV), Gentamicin (IV); diuretic, Mannitol (IV), Metolazone (oral).